Design Therapeutics DSGN
NASDAQ DSGN
$10.72 -0.01 (-0.09%)
As of: Oct 22, 2026 · 10:09 AM EDT

Design Therapeutics (DSGN) Change in Other Operating Liabilities (2020)

Updated

Analysis

Design Therapeutics (DSGN) Change in Other Operating Liabilities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,164.86 Bn 1,133.45 Bn 19.71 Bn -
2 Johnson & Johnson 632.18 Bn 550.71 Bn 17.26 Bn -972.00 Mn
3 AbbVie 503.53 Bn 476.64 Bn 12.70 Bn -
4 Merck 378.03 Bn 332.41 Bn 12.21 Bn -
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn -
6 Astrazeneca 266.38 Bn 240.07 Bn 12.86 Bn -
7 Amgen 241.24 Bn 196.64 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 193.68 Bn 167.88 Bn 6.22 Bn -
9 Pfizer 172.22 Bn 118.87 Bn 10.94 Bn -112.00 Mn
10 Design Therapeutics 668.81 Mn -187.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 136,000.00
Sep 30, 2020 1.82 Mn
Jun 30, 2020 -330,000.00
Mar 31, 2020 -1.68 Mn
API Access

Design Therapeutics Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=DSGN&period=max&api_key=YOUR_API_KEY